Cargando…
Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AIMS Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803786/ https://www.ncbi.nlm.nih.gov/pubmed/31663034 http://dx.doi.org/10.3934/genet.2019.3.64 |
| _version_ | 1783461022909071360 |
|---|---|
| author | Seeruttun, Sharvesh Raj |
| author_facet | Seeruttun, Sharvesh Raj |
| author_sort | Seeruttun, Sharvesh Raj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6803786 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AIMS Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68037862019-10-29 Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety Seeruttun, Sharvesh Raj AIMS Genet Editorial AIMS Press 2019-09-19 /pmc/articles/PMC6803786/ /pubmed/31663034 http://dx.doi.org/10.3934/genet.2019.3.64 Text en © 2019 the Author(s), licensee AIMS Press This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) |
| spellingShingle | Editorial Seeruttun, Sharvesh Raj Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title | Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title_full | Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title_fullStr | Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title_full_unstemmed | Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title_short | Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| title_sort | re-engineering anti-ctla-4 antibodies for enhancing cancer immunotherapy efficacy and safety |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803786/ https://www.ncbi.nlm.nih.gov/pubmed/31663034 http://dx.doi.org/10.3934/genet.2019.3.64 |
| work_keys_str_mv | AT seeruttunsharveshraj reengineeringantictla4antibodiesforenhancingcancerimmunotherapyefficacyandsafety |